Franklin Biotechnology Discovery Fund

Portfolio Statistics

Assets

Total Fund AssetsAs of 06/30/2021 (updated monthly) $1,419.0 (M)
Net Assets - Class R6 As of 06/30/2021 (updated monthly) $17.0 (M)
P/E Ratio (12-mo Forward)As of 06/30/2021 (updated monthly) 15.43
P/B RatioAs of 06/30/2021 (updated monthly) 5.11

Positions As of 06/30/2021

Portfolio Details

Asset AllocationAs of 06/30/2021

[name] [value]
Equity 99.48%
Cash & Cash Equivalents 0.52%

Geographic BreakdownAs of 06/30/2021

[name] [value]
United States 92.74%
Denmark 2.07%
Canada 1.98%
Switzerland 1.49%
Netherlands 1.20%
Cash & Cash Equivalents 0.52%

sector breakdownAs of 06/30/2021

[name] [value]
Biotechnology 78.96%
Pharmaceuticals 11.89%
Life Sciences Tools & Services 6.94%
Diversified Capital Markets 0.85%
Other Diversified Financial Services 0.68%
Cash & Cash Equivalents 0.52%
Health Care Facilities 0.15%

TOP TEN HOLDINGSAs of 06/30/2021

41.91%
Other
0% 100%
[holdings-table-heading]
GILEAD SCIENCES INC 6.74%
AMGEN INC 5.48%
REGENERON PHARMACEUTICALS INC 5.44%
ILLUMINA INC 5.03%
VERTEX PHARMACEUTICALS INC 3.67%
BIOGEN INC 3.62%
HORIZON PHARMA PLC 3.22%
NOVAVAX INC 3.16%
JAZZ PHARMACEUTICALS PLC 2.78%
MIRATI THERAPEUTICS INC 2.77%